FDA Ends Clozapine REMS!
- Feb 25, 2025
- 1 min read
The FDA has made a historic decision to end the clozapine REMS program, effective immediately.
To read the official FDA announcement, click HERE.
Heidi Anne Duerr with Psychiatric Times has published a more detailed announcement:
The FDA still recommends that prescribers monitor patients’ ANC according to the monitoring frequencies described in the prescribing information. However, the FDA does not expect prescribers, pharmacies, and patients to participate in the REMS program or to report results of ANC blood tests before pharmacies dispense clozapine.
We will communicate additional information as it becomes available.
Thank you to Schizophrenia & Psychosis Action Alliance, Team Daniel Running for Recovery from Mental Illness, Dr. Gil Honigfeld, and many other physicians, agencies and advocacy groups that have supported this mission.
Above all, thank you to our heroes and survivors who bravely and publicly shared their hardships accessing clozapine with the entire world.
The Angry Moms
